Naringin enhances CaMKII activity and improves long-term memory in a mouse model of Alzheimer's disease

International Journal of Molecular Sciences

Volumn 14, Issue 3, 2013, Pages 5576-5586

  Wang, Dong Mei ^a,b   Yang, Ya Jun ^b   Zhang, Li ^b   Zhang, Xu ^b   Guan, Fei Fei ^b   Zhang, Lian Feng ^b  

^a HENAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b INSTITUTE OF LABORATORY ANIMAL SCIENCE   (China)

Author keywords

Alzheimer's disease; APPswe PS1dE9 mice; CaMKII; Naringin

Indexed keywords

AMPA RECEPTOR; AURANTIIN; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; DONEPEZIL;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPHOSPHORYLATION; CONTROLLED STUDY; DRUG EFFECT; DRUG ISOLATION; DRUG MECHANISM; DRUG MEGADOSE; DRUG STRUCTURE; ENZYME ACTIVITY; FEMALE; LEARNING; LONG TERM MEMORY; MALE; MAZE TEST; MOUSE; NONHUMAN; PASSIVE AVOIDANCE;

EID: 84875083943     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms14035576     Document Type: Article

References (34)

1. Stokin, G.B.; Lillo, C.; Falzone, T.L.; Brusch, R.G.; Rockenstein, E.; Mount, S.L.; Raman, R.; Davies, P.; Masliah, E.; Williams, D.S.; et al. Axonopathy and transport deficits early in the pathogenesis of Alzheimer's disease. Science 2005, 307, 1282-1288.
2. Ballatore, C.; Lee, V.M.; Trojanowski, J.Q. Tau-mediated neurodegeneration in Alzheimer's disease and related disorders. Nat. Rev. Neurosci. 2007, 8, 663-672.
3. Auld, D.S.; Kornecook, T.J.; Bastianetto, S.; Quirion, R. Alzheimer's disease and the basal forebrain cholinergic system: Relations to beta-amyloid peptides, cognition, and treatment strategies. Prog. Neurobiol. 2002, 68, 209-245.
4. Martinez-Coria, H.; Green, K.N.; Billings, L.M.; Kitazawa, M.; Albrecht, M.; Rammes, G.; Parsons, C.G.; Gupta, S.; Banerjee, P.; LaFerla, F.M. Memantine improves cognition and reduces Alzheimer's-like neuropathology in transgenic mice. Am. J. Pathol. 2010, 176, 870-880
5. Selkoe, D.J. Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior. Behav. Brain Res. 2008, 192, 106-113.
6. Shankar, G.M.; Walsh, D.M. Alzheimer's disease: Synaptic dysfunction and Abeta. Mol. Neurodegener. 2009, 4, 48.
7. Chakroborty, S.; Kim, J.; Schneider, C.; Jacobson, C.; Molgo, J.; Stutzmann, G.E. Early presynaptic and postsynaptic calcium signaling abnormalities mask underlying synaptic depression in presymptomatic Alzheimer's disease mice. J. Neurosci. 2012, 32, 8341-8353
8. Zeng, Y.; Zhao, D.; Xie, C.W. Neurotrophins enhance CaMKII activity and rescue amyloid-beta-induced deficits in hippocampal synaptic plasticity. J. Alzheimer's Dis. 2010, 21, 823-831
9. Schroeter, H.; Boyd, C.; Spencer, J.P.; Williams, R.J.; Cadenas, E.; Rice-Evans, C. MAPK signaling in neurodegeneration: Influences of flavonoids and of nitric oxide. Neurobiol. Aging 2002, 23, 861-880.
10. Pereira, R.M.S.; Andrades, N.E.D.; Paulino, N.; Sawaya, A.C.H.F.; Eberlin, M.N.; Marcucci, M.C., Favero, G.M.; Novak, E.M.; Bydlowski, S.P. Synthesis and characterization of a metal complex containing naringin and Cu, and its antioxidant, antimicrobial, antiinflammatory and tumor cell cytotoxicity. Molecules 2007, 12, 1352-1366.
11. Cui, L.; Zhang, Z.H.; Sun, E.; Jia, X.B. Effect of β-cyclodextrin complexation on solubility and enzymatic conversion of naringin. Int. J. Mol. Sci. 2012, 13, 14251-14261.
12. Golechha, M.; Chaudhry, U.; Bhatia, J.; Saluja, D.; Arya, D.S. Naringin protects against kainic acid-induced status epilepticus in rats: Evidence for an antioxidant, anti-inflammatory and neuroprotective intervention. Biol. Pharm. Bull. 2011, 34, 360-365.
13. Kumar, P.; Kumar, A. Protective effect of hesperidin and naringin against 3-nitropropionic acid induced Huntington's like symptoms in rats: Possible role of nitric oxide. Behav. Brain Res. 2010, 206, 38-46.
14. Kumar, A.; Dogra, S.; Prakash, A. Protective effect of naringin, a Citrus flavonoid, against colchicine-induced cognitive dysfunction and oxidative damage in rats. J. Med. Food 2010, 13, 976-984.
15. Kumar, A.; Prakash, A.; Dogra, S. Naringin alleviates cognitive impairment, mitochondrial dysfunction and oxidative stress induced by D-galactose in mice. Food Chem. Toxicol. 2010, 48, 626-632.
16. Wang, D.M.; Gao, K.; Li, X.Y.; Shen, X.H.; Zhang, X.; Ma, C.M.; Qin, C.; Zhang, L.F. Long-term naringin consumption reverses a glucose uptake defect and improves cognitive deficits in a mouse model of Alzheimer's disease. Pharm. Biochem. Behav. 2012, 102, 13-20.
17. Insausti, R.; Tunon, T.; Sobreviela, T.; Insausti, A.M.; Gonzalo, L.M. The human entorhinal cortex: A cytoarchitectonic analysis. J. Comp. Neurol. 1995, 355, 171-198.
18. Shankar, G.M.; Li, S.; Mehta, T.H.; Garcia-Munoz, A.; Shepardson, N.E.; Smith, I.; Brett, F.M.; Farrell, M.A.; Rowan, M.J.; Lemere, C.A.; et al. Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nat. Med. 2008, 14, 837-842.
19. 2+/calmodulin-dependent protein kinase II levels in Alzheimer's disease. Neuroreport 2005, 16, 1809-1813.
20. Lisman, J.; Yasuda, R.; Raghavachari, S. Mechanisms of CaMKII action in long-term potentiation. Nat. Rev. Neurosci. 2012, 13, 169-182.
21. Strack, S.; Choi, S.; Lovinger, D.M.; Colbran, R.J. Translocation of autophosphorylated calcium/calmodulin-dependent protein kinase II to the postsynaptic density. J. Biol. Chem. 1997, 272, 13467-13470.
22. 2+/calmodulin-dependent protein kinase II is a binding protein for synapsin I. Nature 1992, 359, 417-420.
23. 2+/calmodulin-kinase II enhances channel conductance of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate type glutamate receptors. Proc. Natl. Acad. Sci.USA 1999, 96, 3269-3274.
24. Liu, S.J.; Gasperini, R.; Foa, L.; Small, D.H. Amyloid-beta decreases cell-surface AMPA receptors by increasing intracellular calcium and phosphorylation of GluR2. J. Alzheimer's Dis. 2010, 21, 655-666.
25. Minano-Molina, A.J.; Espana, J.; Martin, E.; Barneda-Zahonero, B.; Fado, R.; Sole, M.; Trullás, R.; Saura, C.A.; Rodríguez-Alvarez, J. Soluble oligomers of amyloid-beta peptide disrupt membrane trafficking of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor contributing to early synapse dysfunction. J. Biol. Chem. 2011, 286, 27311-27321.
26. Lanz, T.A.; Carter, D.B.; Merchant, K.M. Dendritic spine loss in the hippocampus of young PDAPP and Tg2576 mice and its prevention by the ApoE2 genotype. Neurobiol. Dis. 2003, 13, 246-253.
27. Hayashi, Y.; Shi, S.H.; Esteban, J.A.; Piccini, A.; Poncer, J.C.; Malinow R. Driving AMPA receptors into synapses by LTP and CaMKII: Requirement for GluR1 and PDZ domain interaction. Science 2000, 287, 2262-2267.
28. Jourdain, P.; Fukunaga, K.; Muller, D. Calcium/calmodulin-dependent protein kinase II contributes to activity-dependent filopodia growth and spine formation. J. Neurosci. 2003, 23, 10645-10649.
29. Wayman, G.A.; Lee, Y.S.; Tokumitsu, H.; Silva, A.J.; Soderling, T.R. Calmodulin-kinases: Modulators of neuronal development and plasticity. Neuron 2008, 59, 914-931.
30. Zhu, L.Q.; Wang, S.H.; Liu, D.;Yin, Y.Y.; Tian, Q.; Wang, X.C.; Wang, Q.; Chen, J.G.; Wang, J.Z. Activation of glycogen synthase kinase-3 inhibits long-term potentiation with synapse-associated impairments. J. Neurosci. 2007, 27, 12211-12220.
31. Song, B.; Lai, B.; Zheng, Z.; Zhang, Y.; Luo, J.; Wang, C.; Chen, Y.; Woodgett, J.R.; Li, M. Inhibitory phosphorylation of GSK-3 by CaMKII couples depolarization to neuronal survival. J. Biol. Chem. 2010, 285, 41122-41134.
32. Sudto, K.; Pornpakakul, S.; Wanichwecharungruang, S. An efficient method for the large scale isolation of naringin from pomelo (Citrus grandis) peel. Int. J. Food Sci. Tech. 2009, 44, 1737-1742.
33. Reagan-Shaw, S.; Nihal, M.; Ahmad, N. Dose translation from animal to human studies revisited. FASEB J. 2008, 22, 659-661.
34. Laczo, J.; Vlcek, K.; Vyhnalek, M.; Vajnerova, O.; Ort, M.; Holmerova, I.; Tolar, M.; Andel, R.; Bojar, M.; Hort, J. Spatial navigation testing discriminates two types of amnestic mild cognitive impairment. Behav. Brain Res. 2009, 202, 252-259.